| Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer J Tie, JD Cohen, K Lahouel, SN Lo, Y Wang, S Kosmider, R Wong, ... New England Journal of Medicine 386 (24), 2261-2272, 2022 | 644 | 2022 |
| Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer J Tie, JD Cohen, Y Wang, M Christie, K Simons, M Lee, R Wong, ... JAMA oncology 5 (12), 1710-1717, 2019 | 563 | 2019 |
| Clinical features and outcome in HIV-associated multicentric Castleman's disease M Bower, T Newsom-Davis, K Naresh, S Merchant, B Lee, B Gazzard, ... Journal of Clinical Oncology 29 (18), 2481-2486, 2011 | 206 | 2011 |
| Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer B Lee, L Lipton, J Cohen, J Tie, AA Javed, L Li, D Goldstein, M Burge, ... Annals of Oncology 30 (9), 1472-1478, 2019 | 193 | 2019 |
| The efficacy of axillary ultrasound in the detection of nodal metastasis in breast cancer B Lee, AK Lim, J Krell, K Satchithananda, RC Coombes, JS Lewis, ... American Journal of Roentgenology 200 (3), W314-W320, 2013 | 118 | 2013 |
| Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies J Tie, JD Cohen, SN Lo, Y Wang, L Li, M Christie, M Lee, R Wong, ... International journal of cancer 148 (4), 1014-1026, 2021 | 94 | 2021 |
| The efficacy of percutaneous vertebroplasty for vertebral metastases associated with solid malignancies B Lee, I Franklin, JS Lewis, RC Coombes, R Leonard, P Gishen, ... European Journal of Cancer 45 (9), 1597-1602, 2009 | 79 | 2009 |
| Cell cycle control as a promising target in melanoma B Lee, S Sandhu, G McArthur Current opinion in oncology 27 (2), 141-150, 2015 | 71 | 2015 |
| The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma B Lee, A Wong, D Kee, P Neeson, M Shackleton, G McArthur, S Sandhu Annals of Oncology 27 (6), 1174-1177, 2016 | 70 | 2016 |
| Initial feasibility and clinical implementation of daily MR-guided adaptive head and neck cancer radiation therapy on a 1.5 T MR-Linac system: prospective R-IDEAL 2a/2b … BA McDonald, S Vedam, J Yang, J Wang, P Castillo, B Lee, ... International Journal of Radiation Oncology* Biology* Physics 109 (5), 1606-1618, 2021 | 67 | 2021 |
| Impact of primary tumor site on bevacizumab efficacy in metastatic colorectal cancer H Wong, B Lee, K Field, A Lomax, M Tacey, J Shapiro, J McKendrick, ... Clinical colorectal cancer 15 (2), e9-e15, 2016 | 66 | 2016 |
| Towards routine implementation of liquid biopsies in cancer management: it is always too early, until suddenly it is too late MJ IJzerman, J de Boer, A Azad, K Degeling, J Geoghegan, C Hewitt, ... Diagnostics 11 (1), 103, 2021 | 50 | 2021 |
| A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies CW Guo, M Alexander, Y Dib, PKH Lau, AM Weppler, G Au-Yeung, B Lee, ... European journal of cancer 124, 15-24, 2020 | 46 | 2020 |
| Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer JA Shaw, J Brown, RC Coombes, J Jacob, R Payne, B Lee, K Page, ... Biomarkers in medicine 5 (1), 87-91, 2011 | 46 | 2011 |
| BRAF inhibition in BRAF V600E-positive anaplastic thyroid carcinoma AM Lim, GR Taylor, A Fellowes, L Cameron, B Lee, RJ Hicks, ... Journal of the National Comprehensive Cancer Network 14 (3), 249-254, 2016 | 43 | 2016 |
| The clinical significance of radiologically detected silent pulmonary nodules in early breast cancer B Lee, A Lim, A Lalvani, MJL Descamps, R Leonard, S Nallamala, ... Annals of oncology 19 (12), 2001-2006, 2008 | 31 | 2008 |
| Stage-based variation in the effect of primary tumor side on all stages of colorectal cancer recurrence and survival MM Lee, A MacKinlay, C Semira, C Schieber, AJJ Yepes, B Lee, R Wong, ... Clinical colorectal cancer 17 (3), e569-e577, 2018 | 29 | 2018 |
| Serial circulating tumor DNA (ctDNA) analysis as a prognostic marker and a real-time indicator of adjuvant chemotherapy (CT) efficacy in stage III colon cancer (CC). J Tie, J Cohen, Y Wang, M Lee, R Wong, S Kosmider, S Ananda, JH Cho, ... Journal of Clinical Oncology 36 (15_suppl), 3516-3516, 2018 | 29 | 2018 |
| A histone deacetylase inhibitor, panobinostat, enhances chimeric antigen receptor T-cell antitumor effect against pancreatic cancer AI Ali, M Wang, B von Scheidt, PM Dominguez, AJ Harrison, DGM Tantalo, ... Clinical Cancer Research 27 (22), 6222-6234, 2021 | 26 | 2021 |
| CDK4 inhibitors an emerging strategy for the treatment of melanoma B Lee, GA McArthur Melanoma management 2 (3), 255-266, 2015 | 25 | 2015 |
Peter GibbsThe Walter and Eliza Hall Institute Of Medical ResearchVerified email at wehi.edu.au
